- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
Slow news weekend, so we'll post a story by Nathaniel Weixel of The Hill on his divination of GOP healthcare plans. Weixel isn't exactly a nonpartisan observer, even though he would like you to believe he is an independent journalist. So take his prognostications with a large lump of salt:
https://thehill.com/policy/healthcare/5624197-aca-subsidies-republican-options/
What’s on the GOP menu for ObamaCare reform, subsidy extensions
By Nathaniel Weixel - November 27, 2025Twenty-four million Americans are facing spiking health insurance prices because of expiring enhanced Affordable Care Act (ACA) subsidies that Republicans have so far refused to extend.
Lawmakers are divided on the way ahead, with the deadline to sign up for 2026 coverage on Dec. 15.
GOP leaders are faced with competing proposals across the House and Senate but the same political dilemma: Either they extend the subsidies and endorse ObamaCare, which Republicans have long opposed, or they let the subsidies expire ahead of next year’s midterms and deal with the electoral fallout.
Some want a deal to preserve the enhanced subsidies, heading off voter ire and preventing an election-year nightmare scenario for the GOP. Others want the enhanced subsidies to expire and be replaced by direct cash to Americans, convinced they can blame Democrats for high costs.
No matter what happens, the law’s underlying subsidies that help people afford premiums will continue past year’s end. But the expiration of the enhanced subsidies, enacted during the COVID-19 pandemic, means millions will see higher monthly payments.
Here’s what’s on the GOP menu, and who is behind it:
House front-line and moderate GOP
One bill comes from Reps. Don Bacon (R-Neb.), Tom Suozzi (D-N.Y.), Josh Gottheimer (D-N.J.), and Jeff Hurd (R-Colo.).
Their bill would extend ObamaCare’s enhanced subsidies for two years, along with some changes to try to assuage conservatives’ concerns about fraud.
The bill would extend the enhanced tax credits through 2027 for enrollees earning less than $200,000 per year for a family of four, and it would phase out the subsidies for enrollees earning between $200,000 and $300,000 for a family of four.
It would also create new guardrails to prevent “ghost beneficiaries” — ObamaCare enrollees who don’t have any health care claims. It’s one of the main criticisms Republicans have of the subsidies, and they argue it’s an indication of widespread fraud.
The bill would codify the federal government’s authority to remove bad actors from ACA marketplaces and require marketplaces to regularly confirm enrollee eligibility and that enrollees haven’t died.
The bill would also extend open enrollment to May 15 as a recognition that many would-be recipients may have been discouraged from purchasing health insurance by sticker shock over high premiums.
Separately, Bacon joined another small bipartisan group led by California Reps. Kevin Kiley (R) and Sam Liccardo (D) to back a two-year subsidy extension with an income cap that includes a pay-for. It seeks to create savings by cutting “excessive Medicare Advantage payouts to insurers” through the common practice of “upcoding.”
Rep. Jen Kiggans (R-Va.), who’s facing a tough reelection contest, has her own bill promoting a one-year extension. It’s been endorsed by 14 other GOP lawmakers.
Sen. Bill Cassidy (R-La)
The plan from Cassidy, chair of the Senate Health, Education, Labor and Pensions Committee, would let the enhanced subsidies expire.
Congress would then use that funding to deposit money directly into savings accounts (HSAs) for people who buy high-deductible plans on ObamaCare exchanges. The original subsidies would still go toward marketplace premiums.
Giving people HSAs has been a favorite idea among Republicans for years, and it was a key part of the party’s 2017 ACA replacement bills in the House and Senate. The idea appeals to Republicans who want to promote free market competition in health care.
Cassidy argued that offering HSA funds to a patient directly cuts out the insurer and empowers a patient to make their own choices for healthcare.
“We don’t have to be paternalistic,” he said during a recent Finance Committee hearing on health costs.
Cassidy’s plan is not the official Republican position, and he hasn’t released legislation yet. But it aligns with a demand by President Trump to end the enhanced subsidies and send money directly to consumers.
His idea takes advantage of a change made possible by the GOP’s One Big Beautiful Bill Act, which allowed ObamaCare “bronze” plans to be eligible for HSAs. Bronze plans feature lower premiums but high deductibles and only 60 percent coverage for medical expenses.
HSAs can’t be used to pay for monthly premiums, and critics argue that they won’t help if someone can’t afford the underlying cost in the first place. They also are of little help for someone with an expensive medical condition like cancer or diabetes.
Cassidy said he doesn’t have a cost estimate, and he hasn’t worked out how to allocate the HSAs to consumers.
Prior to the Thanksgiving recess, Cassidy said his goal was to have a plan ready to go by mid-December, which is when Senate GOP leaders promised Democrats they would hold a vote on extending the enhanced subsidies.
Sen. Rick Scott (R-Fla.)
Like Cassidy’s idea, Scott’s legislation centers on health savings accounts and would let the enhanced subsidies expire.
But his proposal goes even further than Cassidy’s and could undermine the entire structure of the Affordable Care Act.
Scott’s bill lets states submit a waiver to the federal government to replace the base ACA premium tax credits and instead fund “HSA-style Trump Health Freedom Accounts.”
Unlike traditional HSAs, people could use the funds to pay for both premiums and health expenses. According to the bill, the payments would be effective starting Jan. 1.
According to health research group KFF, the “freedom accounts” could be used for any type of health insurance plan, including short-term plans that can exclude people based on pre-existing conditions, which is not allowed under ObamaCare.
States could also waive certain provisions of the ACA, including the requirement to cover certain benefits. Scott’s plan would allow insurers to sell plans across state lines, opening up the possibility of selling plans that don’t meet a state’s regulatory requirements.
Scott’s plan could lead to a collapse of the ACA marketplace in states that fund the freedom accounts. Healthy people would be able to buy less expensive coverage or skip insurance altogether and use their accounts to pay for health care directly.
People with expensive health conditions would only be able to get coverage from ACA exchange plans.
The White House
President Trump has been sending conflicting messages.
Earlier this month, he posted an all-caps message on Truth Social telling Congress not to “waste your time and energy” on extending the subsidies.
But then a leaked White House plan reported by various outlets was closer to the House moderates’ idea than the ones from Cassidy or Scott.
It involved temporarily extending the ACA subsidies, potentially for two years, while incorporating a series of guardrails, like income eligibility limits and a requirement that all enrollees pay some form of premium. Both those policies seek to address the allegations of fraud.
It also reportedly would have included some incentives for enrollees to choose a high-deductible plan and redirect some federal aid into a health savings accounts.
Yet the apparent trial balloon popped soon after it was leaked. The reports sparked backlash from Republicans, who have spent years railing against the law.
On Nov. 25, Trump told reporters on Air Force One he’d “rather not” extend the subsidies.
“Somebody said I want to extend them for two years. I don’t want to extend them for two years.
I’d rather not extend them at all,” Trump said. “Some kind of extension may be necessary to get something else done, because the un-Affordable Care Act has been a disaster.”
"Premium Support" is the new Washington-speak for subsidies. The new terminology doesn't seem to convince GOP Senators that their constituents should pay for the rest of the country's (and the entire world's) health care:
https://thehill.com/homenews/senate/5628853-enhanced-health-subsidies-fight/
GOP pessimism grows over any deal to extend expiring health care subsidies
By Alexander Bolton - December 2, 2025Senate Republicans don’t see a bipartisan deal to extend enhanced health insurance premium subsidies coming together before the Christmas deadline, given the complexity of the issue and a growing fight over abortion, an issue that deeply divides both parties.
There is a solid group of Republican lawmakers in both the Senate and House who don’t want to see the enhanced subsidies under the Affordable Care Act (ACA) expire at the end of the month.
Many more, however, view ObamaCare as irretrievably broken, and an extension of beefed-up subsidies as policy heresy.
That fracture within the party makes it very difficult to move legislation and is a reason for the GOP pessimism.
Senate Majority Leader John Thune (R-S.D.) acknowledged the lack of progress Monday.
“My assumption is that by next week when we have to have that vote, that we might not be far enough along on the bipartisan discussions,” he told reporters.
Thune said the “conversations are still active on a solution,” but he warned “there are some significant sticking points.”
The GOP leader highlighted an escalating fight over adding language to any bill extending the subsidies to ensure federal money is not spent on abortion care.
“Dealing with Hyde is a big issue, obviously, for both sides,” Thune said, referring to language that prohibits taxpayers’ money being spent on abortions and is named after former Rep. Henry Hyde (R-Ill.).
Democrats argue that under current law, the subsidies do not fund abortions. But Republicans want stricter safeguards and to apply the Hyde Amendment, which prohibits federal funding of apportion, more directly to the health insurance marketplace.
Sen. Tammy Baldwin (Wis.), a leading Democratic voice on health care policy who has participated in Senate negotiations on the issue, said she does not support attaching new abortion-related language to federal insurance subsidies.
“When we enacted the ACA, there were safeguards related to the tax credits and they’ve been sufficient and they remain sufficient, to my mind. So I would not see supporting any additional limitations,” she said Monday while heading into the weekly Democratic leadership meeting.
“I’m certainly involved in the talks, always,” she added.
Sen. Elizabeth Warren (Mass.), another member of the Senate Democratic leadership team, said neither Senate Republican leaders nor the White House have presented any substantive proposals to keep the enhanced subsidies from expiring.
“There are no Republicans willing to negotiate over this. None. Where is Donald Trump? Where is the Republican leadership in the House or the Senate? None of them want to talk about health care assistance for American families,” she said.
“They don’t want to talk to the Democrats about that. They want to go off an engage in some fantasy conversation with each other about people who can afford to pay for health care. They have voted to cut health care, and they don’t want to reverse those cuts,” she added.
Senate Republican Whip John Barrasso (Wyo.) on Monday cast doubt on getting a bipartisan deal before Christmas, asserting Democrats haven’t yet agreed on a proposal to extend the subsidies.
“The Democrats haven’t even come up with a proposal. The House wants three years, someone wants a permanent extension — they don’t know what they want,” he said.
White House advisers last week floated a plan to extend the expiring subsidies temporarily while also reforming the program by imposing an income cap on individuals and families who qualify and cracking down on what Republicans say is rampant fraud.
But Trump last week distanced himself from the proposal after getting pushback from Speaker Mike Johnson (R-La.) and House conservatives.
“I’d rather not extend them at all,” Trump said shortly before Thanksgiving, though he acknowledged that “some kind of extension might be necessary to get something done.”
Speaker Johnson warned Trump advisers in a phone call last week that extending the enhanced ACA subsidies faced strong opposition within the House GOP conference.
Thune told reporters Monday that there’s interest among some Republican senators in extending the subsidies and reforming the ACA health insurance marketplace.
“We have a lot of interest on our side and a lot of good ideas that go back to try and address what we think are some of the underlying problems with ObamaCare in the first place. One being affordability, the fact that premiums continue to escalate year over year, and we think that has a lot to do with the way it’s structured and how it incentivizes insurance companies to cover people,” Thune said Monday evening.
Sen. Josh Hawley (R-Mo.) is warning that the expiration of enhanced subsidies would impact nearly half a million people in his home state.
“We can’t just allow the premium support to expire,” he warned last month.
Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy (R-La.) is working on legislation to convert the ACA’s premium tax credits into contributions to health savings accounts that could be used to defray out-of-pocket health care costs, according to an analysis of his plan by health care research nonprofit KFF.
That proposal has already run into Democratic opposition.
“We insist that the ACA tax credits have to be renewed and extended, period. If Cassidy’s proposal, as I understand it, replaces them, [that] looks like it’s privatizing health insurance, and looks like it’s really problematic,” Senate Democratic Leader Chuck Schumer (D-N.Y.) told reporters before the Thanksgiving recess.
House Democrats are circulating a discharge petition to force a vote in the lower chamber on legislation to extend the enhanced health insurance subsidies for three years.
But Republican leaders are skeptical that Democrats can get the 218 signatures to force a vote, and even if they prevail in the House, there’s no guarantee that legislation to extend the subsidies without significant reforms could get the 60 votes needed to pass the Senate.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













